VX15/2503
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for VX15/2503, covering 2014-08-13 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer [Phase 1]